T he prevalence of chronic kidney disease (CKD) has increased during the past years worldwide, 1 imposing a major burden on health-care systems. It is important to prevent CKD, thereby to reduce the need for renal replacement therapy and the rising morbidity and mortality associated with end-stage renal disease.
T he prevalence of chronic kidney disease (CKD) has increased during the past years worldwide, 1 imposing a major burden on health-care systems. It is important to prevent CKD, thereby to reduce the need for renal replacement therapy and the rising morbidity and mortality associated with end-stage renal disease. 2 Therefore, an efficient individual prediction of CKD progression is warranted.
Several factors are involved in CKD progression, including baseline renal function, age, ethnicity, diabetes mellitus, blood pressure, use of renin-angiotensin system (RAS) blocker, and albuminuria. [3] [4] [5] [6] [7] [8] [9] Despite these single predictive factors, an individual prediction of CKD progression remains difficult. Interestingly, all of the factors described above additionally influence the microcirculation and contribute to intraglomerular pressure. [10] [11] [12] [13] [14] [15] [16] Thus, it is not surprising that renal microvascular pathology has been considered an important factor in CKD progression. 17 One pathophysiological aspect of the microcirculation is vascular remodeling in small arteries, including microvascular narrowing. 18, 19 The latter can be assessed by noninvasive retinal vessel analysis. 20, 21 Narrow retinal arterioles are associated with age, black race, hypertension, and albuminuria. Ooi et al 22 and our group described narrow retinal arteries in patients with advanced CKD. 23, 24 Similar to systemic arteriolar narrowing, the retinal and preglomerular arterioles could show the same effects. 25 Narrow preglomerular arterioles increase intraglomerular pressure and contribute to the glomerular defect, determined by albuminuria, as has been demonstrated in spontaneously hypertensive rats and in patients with diabetes mellitus. arteriolar narrowing and albuminuria, the 2 different components of the microcirculation, act synergistically on CKD progression. Thus, patients demonstrating retinal arteriolar narrowing and albuminuria have an increased risk for CKD progression. In constrast, patients without arteriolar narrowing and albuminuria should present a low risk of CKD progression. In this case, investigations combining albuminuria and retinal arterioles could improve discrimination between stable and advancing CKD, as well as direct health care resources to those in dire need.
Cross-sectional studies demonstrated that arterioles in patients with CKD are narrower as compared with healthy controls. 22, 23, 29, 30 Prospective data of retinal arteriolar narrowing in CKD progression have not been evaluated yet. We performed a prospective study in a CKD stage 2 to 4 cohort. The primary end point was a combined renal end point of 50% renal function loss and start of renal replacement therapy, based on the findings of arteriolar narrowing and albuminuria.
Methods
Patients were recruited from the Nephrological Department of the Klinikum rechts der Isar and the Nephrological Clinic Weissenburg between 2008 and 2009. In all patients, retinal vessel analysis was performed, renal function and office blood pressure assessed, and retinal vessel diameter determined. We included patients with CKD stage 2 because they have elevated cardiovascular risk as compared with renal-healthy controls. 31 We excluded patients with CKD stage 5 because they may show an extremely high event rate, which could influence renal end points. Patients were excluded if presently in hospital, had an acute disease, consent not obtained, CKD stage 5, or no valid retinal photography available. Renal end points were defined as 50% loss of renal function as compared with baseline data or start of renal replacement therapy during the observational period from 2008 until Spring 2013. Renal end point cases and deaths were ascertained by annual contact with patients and centers. When a renal end point was identified, exact date was determined by means of laboratory value and start of renal replacement therapy.
This study has been performed in accordance with the Declaration of Helsinki (2000) of the World Medical Association and approved by the local ethics committee of the institution. Written informed consent was obtained from each patient after full explanation of the purpose, nature, and risk of all procedures.
Glomerular filtration rate was estimated (eGFR) according to the Modification of Diet in Renal Disease in patients with CKD. Albuminuria was assessed in morning spot urine using the ratio of albuminuria and urinary creatinine. The level of creatinine >300 mg/g determined albuminuria.
Cardiovascular risk factors were evaluated and biological parameters measured according to the recommendations of the American and European Clinical Practice Guidelines. The total number of antihypertensive drugs used was recorded, in particular calcium channel blockers and RAS blockers.
Two trained clinicians measured anthropometric characteristics and body mass index independently. Venous blood samples, collected after overnight fasting, were analyzed by standard automated methods for lipids and blood glucose. Office blood pressure was determined in the sitting position after a 5-minute period of rest (Omron, Tokyo, Japan). The values represent the mean of ≥3 measurements. Two trained clinicians performed retina measurements independently.
To measure and summarize retinal vessel diameters from digitized photographs, a standardized protocol as described elsewhere was adopted. 20, 23 In brief, two 30° color retinal photographs of the left eye and 2 photographs of the right eye were taken at baseline. They were digitized using a high-resolution scanner with standard settings (IMEDOS, Jena, Germany). Using a computer program, the graders who were masked to the characteristics of patients measured the diameters of all arterioles and venules in a specified zone surrounding the optic disc. These measurements were combined into summary indices-central retinal arteriolar and venular equivalents-and expressed as the retinal arteriolar-venular ratio. The retinal measures represent the mean of 4 photographs. The eye-to-eye reproducibility was 0.89; intraobserver reproducibility, 0.87; and interobserver reproducibility, 0.78.
All analyses were performed with SPSS version 19.0 (SPSS Inc, Chicago, IL). The categorical data are reported as frequencies and percentages. Mean and SD or median and range were used for continuous data. Friedmann test and ANOVA with post hoc Bonferroni correction were used to compare the baseline characteristics of patients with CKD stage 2 to 4 and the tertiles of central retinal arteriolar equivalent (CRAE).
Using log-rank test, we calculated Kaplan-Meier cumulative renal survival from tertiles of CRAE and expressed it as 100×(1−Kaplan-Meier estimators). Relative risks for renal end points were derived from Cox proportional hazards regression. Univariate and multivariate models were constructed, controlling for age and baseline renal function (eGFR). To test the interaction between the cut-off value of CRAE (upper end of the lower tertile; 163 μm) and albuminuria, specific Cox regression was used before and after adjusting for age and baseline renal function (eGFR). To assess the effects of reclassification in Kaplan-Meier survival, we further classified CRAE (lower tertile versus combined middle and upper tertiles) and albuminuria (albuminuria versus no albuminuria).
Results
We recruited 164 patients with CKD stage 2 to 4 from the nephrological centers of Klinikum rechts der Isar and Weissenburg. In 4 patients, retinal vessel analysis was impossible because they were blind, and in 3 patients, mydriasis was not performed because of glaucoma. In 8 patients, advanced cataract prevented the evaluation of retinal vessel analysis. During the study, 5 patients were excluded because they were identified as CKD stage 5. Three patients were lost of follow-up.
Final analysis was performed on 141 patients with CKD. Diabetes mellitus (n=45; 32%), glomerulonephritis (n=31; 22%), hypertension/renovascular disease (n=27; 19%), reflux nephropathy and other structural malformations (n=9; 6%), polycystic kidney disease (n=8, 6%), or other (cancer, trauma, nephrotoxic agents, or unknown; n=21; 15%) were underlying diseases.
Forty-three patients were in CKD stage 2 (30%), 63 in stage 3 (45%), and 35 in stage 4 (25%), and their mean eGFR was 46 (range, 16-88) mL/min per 1.73 m 2 . The median observation period was 1410 (range, 106-1606) days, during which 25 renal end points occurred and 20 patients died. Characteristics of patients are shown in Table 1 . In CKD stage 2, 3 patients reached the renal end point. None of them was on dialysis. They lost 50% of eGFR. In CKD stage 3, 11 patients reached the combined renal end point. Five patients started dialysis, and additional 6 patients lost >50% of eGFR without need of dialysis. In CKD stage 4, 11 patients reached the combined renal end point. Ten patients started dialysis. One of them lost >50% of eGFR without need of dialysis. Table S1 in the online-only Data Supplement presents the characteristics of patients with renal end point.
We divided patients on dialysis into tertiles of retinal arterial diameter (CRAE). Narrowest arterioles (≤163 μm) were in the first tertile, and largest arteriolar diameters (>178 μm) were in the upper tertile. The cross-sectional stratification of the CKD cohort according to arteriolar diameter did not demonstrate differences in renal function, blood pressure, and lipid levels throughout CRAE tertiles except for proteinuric patients (Table 2) .
Factors associated with renal end points were assessed in Cox regression analysis. In unadjusted analysis, eGFR, albuminuria, and narrow arterioles were associated with renal end points. After adjustment for age and eGFR, the presence of albuminuria and narrow arterioles remained predictive for renal end points (Table 3) .
Next, using the hazard ratio (HR), we assessed the ability of albuminuria and narrow arterioles (lower tertile of CRAE), alone and in combination, to predict renal end points. Albuminuria alone had an HR of 5.4 and narrow arterioles an HR of 3.7 (both P<0.001). In the case of either albuminuria or narrow arterioles, the HR was 4.9. In the case of albuminuria and narrow arterioles combined, the HR was 16.2 (Table 4) , wherein two thirds of all patients reached the renal end points during the observation period. By contrast, 3 of 74 patients reached the renal end points on excluding albuminuria and narrow arterioles. Patients with both factors positive or both factors negative represented 69% of the cohort. Patients with 1 factor positive numbered 44 (HR=4.9). Furthermore, we asked whether an interaction exists between albuminuria and narrow arterioles using unadjusted and adjusted Cox regression analysis (Table 3) . Our data confirm the interaction between both factors.
Using Kaplan-Meier curves with log-rank test, we found that albuminuria and narrow arterioles significantly impaired renal survival (Figure 1 ). Patients with albuminuria and narrow arterioles had early and steep reduction in renal survival (Figure 2A ). By contrast, in patients with CKD without albuminuria and wider arterioles, renal function remained unaffected throughout the observational period (P<0.001). Patients with albuminuria or narrow arterioles significantly more often reached the renal end point (P=0.007) as those without albuminuria and wider arterioles. Patients with one factor positive had a significantly lower rate of renal end points as patients with both factors positive (P<0.001).
This resulted in the risk stratification of CKD progression ( Figure 2B ). When albuminuria was present, 42 (30%) patients had an increased risk for CKD progression. With the inclusion of narrow arterioles, 23 patients (16%) were at higher risk of CKD progression. The risk stratification of CKD progression was also assessed in 99 patients (70%) previously considered at low risk for CKD progression based on missing albuminuria. In these patients, narrow arterioles were present in 25 cases (17%). These patients had a risk ACR indicates albumin-creatinine ratio; AVR, arteriolar-venular ratio; BMI, body mass index; CKD, chronic kidney disease; CRAE, central retinal arteriolar equivalent; CRVE, central retinal venular equivalent; DBP, diastolic blood pressure; eGFR, estimated glomerular filtration rate; HbA1c, hemoglobin A1c; LDL, low-density lipoprotein; RAS, renin-angiotensin system; and SBP, systolic blood pressure.
by guest on July 11, 2017 http://hyper.ahajournals.org/ Downloaded from comparable with that of the 19 patients with albuminuria but wider arterioles (14%). By contrast, 74 patients without albuminuria and wider arterioles had a very low risk of CKD progression (53%). Taken together, 123 of 141 (86%) patients with CKD were reclassified into higher-or lower-risk groups in this study.
During the observational period, 20 patients died. Death was similarly distributed between both groups and did not affect the prediction of renal end points. In this cohort, albuminuria, narrow arterioles, or their combination did not predict mortality (data not shown).
Discussion
This study has identified narrow retinal arterioles as a novel predictor for renal end points and demonstrated its synergistic interaction with albuminuria. The functional relevance of this finding is that narrow arterioles and albuminuria in combination resulted in a synergistic predictive value and allowed a reclassification of patients based on their tendency to reach renal end points. The combination of narrow arterioles and albuminuria had the worst prognosis.
Narrow arterioles are associated with several factors, including aging, hypertension, use of RAS blockers, and impaired renal function, which reflect systemic vascular alterations as a result of vascular remodeling. [32] [33] [34] The ability of these factors to predict renal disease progression has been evidenced. 5, 27, 35 We relate narrow arterioles as the common trunk of these factors on the microcirculation. Based on this idea, the evidence of narrow retinal arterioles reflects a predictive parameter that summarizes the effect of age, blood pressure, RAS blockade, and renal function on the microcirculation. Up to now, cross-sectional data suggesting an association between renal function and narrow arteries are scare. 22 This prospective cohort study proposed retinal arterioles as a quantitative measure in predicting renal progress in CKD stage 2 to 4.
Whereas narrow arterioles reflect a state of vascular remodeling, albuminuria reflects microcirculatory damage as an independent predictor for renal disease progression. 32, [36] [37] [38] If microcirculatory remodeling and damage are both involved in renal disease progression, the interaction of both factors (narrow arterioles and albuminuria) is proposed. 39 In the case of narrow arterioles and albuminuria combined in patients with CKD, a synergistic risk for developing renal end points may be suggested.
However, the confidence intervals overlapped, possibly rendering the interaction between the 2 markers ineffective. Regardless, after adjusting for age and eGFR, our model remained stable. We further performed additional adjustment for diabetes mellitus, systolic blood pressure, and RAS CRAE tertile 1, ≤163 μm; tertile 2, >163 to ≤178 μm; tertile 3, >178 μm. ACR indicates albumin-creatinine ratio; AVR, arteriolar-venular ratio; BMI, body mass index; CRAE, central retinal arteriolar equivalent; CRVE, central retinal venular equivalent; DBP, diastolic blood pressure; eGFR, estimated glomerular filtration rate; HbA1c, hemoglobin A1c; LDL, low-density lipoprotein; RAS, renin-angiotensin system; and SBP, systolic blood pressure. by guest on July 11, 2017 http://hyper.ahajournals.org/ Downloaded from blockade. The results remained stable for the combined action of albuminuria and retinal narrowing. Thus an interaction between the 2 factors is evident despite large confidence intervals. On the contrary, in patients in whom both factors were negative, the risk of progression was markedly reduced. Therefore, we translated the role of remodeling of small arteries in renal failure studies in rats. 40 Improvement in prediction performance can be quantified by the increased proportion of subjects belonging to low-and high-risk categories by the addition of a new predictor to the risk model. 41 Here, the clinical consequence of the synergistic interaction between narrow arterioles and albuminuria was a reclassification of 86% of all patients according to their risk to reach renal end points as estimated on albuminuria This study, however, had several limitations. The patients with CKD investigated were relatively small in number, with low event rate, based on 2 recruiting centers, and predominantly whites. As a consequence, we restricted adjustment to 2 factors. Prospective multicenter studies with a larger patient population are needed to confirm these results and to introduce an appropriate cut-off value for narrow arterioles in the prediction of renal end points in patients with CKD.
In summary, this prospective cohort study in white patients with CKD stage 2 to 4 demonstrated that narrow retinal arterioles are a predictitor of renal end points. In addition, the interaction of this microcirculatory factor and albuminuria was evidenced, allowing risk 
Perspective
Efficient individual prediction of advancing CKD is an important development in the field of nephrology. This prospective cohort study describes that narrow retinal arterioles and albuminuria, the 2 microcirculatory factors, synergistically predict CKD progression. This may offer the opportunity to investigate the effects of both the microcirculatory factors on CKD progression in larger, multicenter studies. This should allow the reclassification of patients into lowand high-risk groups according to these combined microcirculatory measures.
